• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Conference outputs
    • View Item
    • Home
    • Griffith Research Online
    • Conference outputs
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Crushing and altering medications in Queensland hospitals.

    Thumbnail
    View/Open
    39385_1.pdf (18.78Kb)
    Author(s)
    Haywood, Alison
    Nissen, L
    Gardiner, E
    Griffith University Author(s)
    Haywood, Alison
    Year published
    2006
    Metadata
    Show full item record
    Abstract
    Medications are often altered or crushed for ease of administration in patients with swallowing difficulties, paediatric patients, patients who require non-standard doses or for tube feeding. Modifying a commercially available medication may lead to increased toxicity, undesirable side effects, decreased efficacy, unpalatability, instability of the active ingredient or create potential hazards to health care workers. Further, this practice may breach legal and professional requirements since use of the altered medication will be deemed to be 'unlicensed'. The objective of this study was to identify which medications are most ...
    View more >
    Medications are often altered or crushed for ease of administration in patients with swallowing difficulties, paediatric patients, patients who require non-standard doses or for tube feeding. Modifying a commercially available medication may lead to increased toxicity, undesirable side effects, decreased efficacy, unpalatability, instability of the active ingredient or create potential hazards to health care workers. Further, this practice may breach legal and professional requirements since use of the altered medication will be deemed to be 'unlicensed'. The objective of this study was to identify which medications are most commonly crushed or altered prior to administration to patients in Queensland (QLD) hospitals, including the specific methods involved in altering the medication, and a detailed description of any extemporaneous formulation employed. A self-report survey was distributed to 97 QLD health facilities classified as a 'hospital' according to QLD Health criteria. An equal distribution of rural and metropolitan hospitals responded (39.17%; n=38). 105 different medications were altered at the bedside, primarily for the adult population (83.8%), with most medications being altered on a daily basis (84.0%). Tablets were crushed (288 observations, 75.4%) by a variety of methods and capsules were opened in 65 observations (17.0%). In a majority of cases (262 observations, 68.6%) more than one medication was mixed together, with popular mixers including jam, water and food. 31 different medications were compounded in the pharmacy, primarily for children (84.6%), with the active ingredient obtained principally by crushing tablets (69.2%) and opening capsules (12.8%). A variety of formularies were used, with varying preparation frequency and expiry dates. This survey has identified that altering commercial medications at the bedside and in the pharmacy (i.e. compounding) is common practice in a sample of QLD hospitals. Administering extemporaneous oral liquid formulations is a daily experience and challenge for many hospital pharmacists and this survey has identified some commonly altered medications, thereby providing specific targets for future physicochemical stability studies to ensure that safe, effective and high quality products are delivered to patients.
    View less >
    Conference Title
    Proceedings of the APSA (Australasian Pharmaceutical Science Association)
    Publisher URI
    http://www.apsa-online.org/
    Copyright Statement
    © 2006 APSA. This is the author-manuscript version of this paper.
    Publication URI
    http://hdl.handle.net/10072/14752
    Collection
    • Conference outputs

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander